Details for New Drug Application (NDA): 206309
✉ Email this page to a colleague
The generic ingredient in TEMOZOLOMIDE is temozolomide. There are sixteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the temozolomide profile page.
Summary for 206309
Tradename: | TEMOZOLOMIDE |
Applicant: | Rising |
Ingredient: | temozolomide |
Patents: | 0 |
Pharmacology for NDA: 206309
Mechanism of Action | Alkylating Activity |
Suppliers and Packaging for NDA: 206309
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TEMOZOLOMIDE | temozolomide | CAPSULE;ORAL | 206309 | ANDA | Rising Pharma Holdings, Inc. | 16571-816 | 16571-816-02 | 20 CAPSULE in 1 BOTTLE (16571-816-02) |
TEMOZOLOMIDE | temozolomide | CAPSULE;ORAL | 206309 | ANDA | Rising Pharma Holdings, Inc. | 16571-816 | 16571-816-41 | 14 CAPSULE in 1 BOTTLE (16571-816-41) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 5MG | ||||
Approval Date: | Apr 27, 2016 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 20MG | ||||
Approval Date: | Apr 27, 2016 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | Apr 27, 2016 | TE: | AB | RLD: | No |
Complete Access Available with Subscription